Chang-guo Zhan

University of South Carolina at Columbia

NIH Rank #5753
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,753
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 4 grants · National rank #5753.

Top grants by award amount

Chang-guo Zhan's NIH grant portfolio, ranked by award amount.

  • 2R01DA035714-11A1R01
    Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine
    $696.1K
    award amount
  • 5R01DA057866-02R01
    Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse
    $642.3K
    award amount
  • 5UG3NS134920-02UG3
    Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning
    $533K
    award amount
  • 5P20GM130456-05P20
    Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation
    $49.5K
    award amount

Affiliations

Institutions that have administered grants for Chang-guo Zhan.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of South Carolina at Columbia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5753
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions